F5 Networks (FFIV) 123.18 $FFIV Juniper (JNPR) Earnings

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
F5 Networks (FFIV) 123.18 $FFIV

Juniper (JNPR) Earnings In Line, Revenues Top; Shares Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 8:54AM CDT
Shares of Juniper Networks Inc. (JNPR) gained more than 6% in yesterday's after-hours trading session following the better-than-expected first-quarter 2015 results.
FFIV: 123.18 (+0.78), CRUS: 33.77 (-0.59), CSCO: 28.82 (+0.15), JNPR: 26.14 (+2.14)

F5 now up 3.6% following earnings, CEO news
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 11:49AM CDT

FFIV: 123.18 (+0.78)

F5 Networks (FFIV) Showing Unusual Social Activity Today
at The Street - Thu Apr 23, 9:20AM CDT
Trade-Ideas LLC identified F5 Networks (FFIV) as an unusual social activity candidate
FFIV: 123.18 (+0.78)

F5 Networks Q2 Earnings In Line, Falls on Soft Revenue View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 8:48AM CDT
F5 Networks Inc. (FFIV) reported second-quarter fiscal 2015 adjusted earnings per share of $1.21, which came in line with the Zacks Consensus Estimate.
IM: 25.65 (+0.08), AVT: 43.47 (-0.28), FFIV: 123.18 (+0.78), JNPR: 26.14 (+2.14)

F5 Networks (FFIV) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Thu Apr 23, 7:14AM CDT
The following F5 Networks (FFIV) conference call took place on April 22, 2015, 04:30 PM ET. This is a transcript of that earnings call:
FFIV: 123.18 (+0.78)

Downgrade Alert for F5 Networks (FFIV)
Comtex SmarTrend(R) - Thu Apr 23, 7:09AM CDT
F5 Networks (NASDAQ:FFIV) was downgraded from Buy to Neutral at MKM Partners today. The stock closed yesterday at $120.42 on volume of 1.7 million shares, above average daily volume of 1.1 million. F5 Networks has overhead space with shares priced $120.42, or 7.3% below the average consensus analyst price target of $129.94. F5 Networks shares have support at the 200-day moving average (MA) of $119.74 and additional support at the 50-day MA of $115.54.
FFIV: 123.18 (+0.78)

Upgrade Alert for F5 Networks (FFIV)
Comtex SmarTrend(R) - Thu Apr 23, 7:08AM CDT
F5 Networks (NASDAQ:FFIV) was upgraded from Hold to Buy at Needham today. The stock closed yesterday at $120.42 on volume of 1.7 million shares, above average daily volume of 1.1 million. F5 Networks, Inc. provides integrated Internet traffic management solutions designed to improve the availability and performance of mission-critical Internet-based servers and applications. The Company's software-based solutions manage, control and optimize Internet traffic and content. F5's solutions automatically deliver Internet content for service providers and e-businesses.
FFIV: 123.18 (+0.78)

F5 Networks' (FFIV) CEO John McAdam on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 7:16PM CDT

FFIV: 123.18 (+0.78)

F5 NETWORKS
at Investor's Business Daily - Wed Apr 22, 5:43PM CDT
F5 NETWORKS (FFIV) beat Q2 views and named exec VP Manny Rivelo as CEO as of July 1. The data center equipment maker's Shares fell 3%.
FFIV: 123.18 (+0.78)

F5 beats Street 2Q forecasts
Automated Insights - Wed Apr 22, 3:58PM CDT
SEATTLE (AP) _ F5 Networks Inc. (FFIV) on Wednesday reported fiscal second-quarter earnings of $85.7 million.
FFIV: 123.18 (+0.78)

F5 names new CEO, offers light sales guidance; shares -3.8%
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 3:52PM CDT

FFIV: 123.18 (+0.78)

F5 Networks (FFIV) Stock Declines in After-Hours on Weak Revenue Guidance Despite Earnings Beat
at The Street - Wed Apr 22, 3:37PM CDT
F5 Networks (FFIV) shares are falling after the company issued weak third quarter revenue guidance.
FFIV: 123.18 (+0.78)

F5 Networks (FFIV) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Apr 22, 3:25PM CDT

FFIV: 123.18 (+0.78)

Manuel Rivelo Appointed as the New CEO of F5 Networks
Business Wire - Wed Apr 22, 3:13PM CDT
F5 Networks (NASDAQ:FFIV) announced today that Manny Rivelo has been named as the company's President and Chief Executive Officer and a member of F5's Board of Directors effective July 1, 2015. Previously, Rivelo served as F5's Executive Vice President of Strategic Solutions. He succeeds longtime CEO, John McAdam, who will become Chairman of the Board of Directors upon his retirement on July 1st. Al Higginson, who has been on the F5 Board of Directors since 1996, and has served as Board Chairman since 2004, will remain on F5's Board as Lead Independent Director, also effective July 1, 2015.
FFIV: 123.18 (+0.78)

F5 Networks beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 3:07PM CDT

FFIV: 123.18 (+0.78)

F5 Networks Announces Results for Second Quarter of Fiscal 2015
Business Wire - Wed Apr 22, 3:05PM CDT
For the second quarter of fiscal 2015, F5 Networks, Inc. (NASDAQ:FFIV) announced revenue of $472.1 million, up 2 percent from $462.8 million in the prior quarter and 12 percent from $420.0 million in the second quarter of fiscal 2014.
FFIV: 123.18 (+0.78)

Watch for F5 Networks to Potentially Pullback After Gaining 1.28% Yesterday
Comtex SmarTrend(R) - Tue Apr 21, 5:46PM CDT
F5 Networks (NASDAQ:FFIV) traded in a range yesterday that spanned from a low of $118.04 to a high of $119.24. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $118.67 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FFIV: 123.18 (+0.78)

SmarTrend Watching for Potential Pullback in Shares of F5 Networks After 1.28% Gain
Comtex SmarTrend(R) - Tue Apr 21, 5:45PM CDT
F5 Networks (NASDAQ:FFIV) traded in a range yesterday that spanned from a low of $118.04 to a high of $119.24. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $118.67 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FFIV: 123.18 (+0.78)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 4:35PM CDT

SKX: 89.66 (+2.79), SLG: 128.82 (+1.47), AMP: 127.75 (+0.58), CTXS: 66.99 (-0.35), WSTC: 32.20 (-0.01), SLM: 10.25 (+0.02), CAKE: 52.98 (+0.56), WFT: 14.16 (-0.05), TYL: 132.12 (+1.82), FFIV: 123.18 (+0.78), LOGI: 15.01 (-0.47), MKSI: 35.94 (+0.44), FTK: 14.06 (-0.43), AHL: 47.77 (-0.09), TMK: 56.09 (-0.11), HNI: 51.98 (+0.71), FOE: 12.62 (unch), FB: 81.53 (-0.88), PLCM: 12.94 (-0.15), CLB: 124.69 (-0.63), XLNX: 42.88 (-0.88), RJF: 57.06 (-0.50), TXN: 54.73 (+0.01), AF: 13.05 (-0.06), VMI: 124.44 (+1.30), CCI: 85.98 (-0.66), OII: 54.10 (-1.47), CLW: 64.38 (+0.21), AFOP: 19.33 (-0.43), SGMO: 14.70 (-0.84), LVS: 55.25 (+0.13), AWH: 41.69 (-0.02), TSCO: 90.98 (-0.28), USTR: 42.07 (-0.28), CVA: 20.97 (-0.40), T: 34.01 (-0.22), EBAY: 59.20 (+0.31), IBKC: 62.86 (-0.61), CNMD: 53.40 (-0.83), QCOM: 68.24 (-0.10), PLXS: 44.20 (-0.32), BDN: 15.00 (+0.35), SUSQ: 13.40 (-0.01), NEU: 461.52 (-7.91), GGG: 71.11 (-1.09), ORLY: 229.35 (+1.04), CYS: 9.15 (+0.05), LHO: 38.40 (-0.10), EFX: 98.49 (+0.09), CUB: 50.07 (-0.15), ALGT: 168.12 (+1.10), TCBI: 51.61 (-0.61), SCSS: 34.50 (+0.86), CLGX: 39.45 (+0.23), IGT: 20.21 (+0.21)

F5's Q2 Earnings Preview: 2015 To Be Another Year Of Strong Growth
Trefis - Seeking Alpha - Tue Apr 21, 3:27PM CDT
F5 Networks (NASDAQ: FFIV ), which specializes in application delivery networking technology, is set to report its Q2 2015 earnings on April 22nd. (Fiscal years end with September.) Fiscal 2014 was a good year for the company as it reported a 17.2%...
FFIV: 123.18 (+0.78), CTXS: 66.99 (-0.35), CSCO: 28.82 (+0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 171

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 219

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 137

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 74

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 102

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 161

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 169

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

Critical Insights on Rising Breast Cancer in Younger Women

Updated Category News Views 204

Understanding the Alarming Trends in Breast Cancer Recent research has uncovered concerning statistics regarding breast cancer in younger women, specifically those aged 18 to 49. A comprehensive study conducted across multiple outpatient facilities has revealed a significant portion of breast cancer diagnoses among this demographic, raising urgent questions about current...

Continue Reading
Asseta: Transforming Family Office Management with AI Solutions

Updated Category News Views 2347

Asseta Unveils Its Rebrand and Advanced AI Offerings In a significant development, Prismatic has rebranded to become Asseta, a transformation that underscores its dedication to providing innovative financial management solutions tailored specifically for family offices. This transition not only marks a shift in branding but signals a deeper commitment to enhancing the...

Continue Reading
Understanding Microsoft's Recent Options Activity and Trends

Updated Category News Views 124

The Surge in Microsoft Options Trading Investors with substantial capital have adopted a bullish approach towards Microsoft (NASDAQ: MSFT). This trend is essential for both institutional and retail traders alike to grasp their positions in the market. What Unusual Trading Movements Reveal Today, a noteworthy surge in options trades for Microsoft caught our attention...

Continue Reading
Eilean Therapeutics Expands Clinical Trials with ZE74-0282 Innovation

Updated Category News Views 103

Eilean Therapeutics Progresses ZE74-0282 into Clinical Trials Eilean Therapeutics has announced an exciting advancement in their pipeline with the development of ZE74-0282, now entering its first-in-human clinical trials. This innovative treatment aims to battle myeloproliferative neoplasms, particularly focusing on the JAK2 V617F mutated variant that poses significant...

Continue Reading
Supermicro's Open Storage Summit Highlights AI's Storage Revolution

Updated Category News Views 236

Supermicro's Open Storage Summit: A Game Changer The Open Storage Summit, hosted by Super Micro Computer, Inc. (SMCI), is gearing up to make waves in the tech industry. This year marks the sixth installment of the summit, which will be running from August 12 to August 28, featuring nine insightful sessions and the participation of 23 companies and 40 speakers. The event...

Continue Reading